Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,828 signal articles · 386 in last 24h · 113,331 total before filter · latest 31m ago
386last 24h
2072last 7d
345● bullish (7d)
181● bearish (7d)
204publishers
AllMacro325Earnings1121M&A95Regulatory24Product17Analyst22
✕ clear all filtersticker: GSSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Inflation Risks Flare Up Ahead of Crucial Week for Wall Street
Barrons.com31d agoneutral
Inflation Risks Flare Up Ahead of Crucial Week for Wall Street

Federal Reserve interest-rate hikes are back in focus this week, thanks to rising inflation concerns following another surge in crude-oil prices. The U.S. and Iran traded fresh strikes over the weekend, and continued to dispute control of oil and energy flows through the Strait of Hormuz, after the breakdown of peace talks aimed at ending a conflict that has simmered for more than 4½ months. U.S. Central Command said around 140 Iranian targets were hit, while military officials from Tehran launched strikes on U.S. bases in the Gulf region, as well as a Kuwait-owned drilling installation.

Bloomberg31d agoneutral
Saudi Tech Firm NourNet Is Said to Pick Goldman, HSBC for IPO

(Bloomberg) -- Saudi Arabia’s NourNet is working with Goldman Sachs Group Inc. and HSBC Holdings Plc on a potential initial public offering, according to people familiar with the matter, adding to a pipeline of Gulf listings despite the regional conflict.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Hormuz Route Open Despite Iran Declaration, Maritime Group SaysOpenAI Engineer’s ‘LOL’ Moment Set Stage for Legal Fight With AppleTrump Embraces Australian Retireme

Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks
Barrons.com31d agoneutral
Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks

After a rocky start to the year, health insurer stocks have roared back. The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic. The fund’s top 10 holdings encompass six health insurers, three of which— UnitedHealth Group Aetna parent CVS Health and Elevance Health —comprise more than 40% of the fund.

Goldman Sachs turns bearish on Barbie maker
TheStreet31d agoneutral
Goldman Sachs turns bearish on Barbie maker

Wall Street has spent most of 2026 losing patience with Mattel (MAT), and Goldman Sachs just made that clear. The firm downgraded the toy giant to its lowest rating and set a price target below where the stock currently trades. For the company behind Barbie and Hot Wheels, this is a tough ...

Bloomberg31d agobullish
Oil Climbs, US Futures Dip on Fresh Iran Strikes: Markets Wrap

(Bloomberg) -- Oil jumped and US equity futures fell after the US launched another round of strikes against Iran, while conflicting claims over the status of the Strait of Hormuz heightened uncertainty.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Hormuz Route Open Despite Iran Declaration, Maritime Group SaysOpenAI Engineer’s ‘LOL’ Moment Set Stage for Legal Fight With AppleUS Launches Fresh Iran Strikes as Tehran Declares Hormuz ClosedGraham Death Sets Up Suc

Qualcomm's datacenter ambitions win over Goldman Sachs
TheStreet33d agoneutral
Qualcomm's datacenter ambitions win over Goldman Sachs

Qualcomm’s push into artificial intelligence data centers has convinced Goldman Sachs to raise its price target by nearly a quarter. The bank kept its rating at Neutral anyway, a sign that even a bullish estimate revision isn’t the same as a buy call. Shares have already sailed past Goldman’s new ...

Goldman Sachs doubles down on Applied Materials stock target
TheStreet33d agoneutral
Goldman Sachs doubles down on Applied Materials stock target

Semiconductor equipment makers have spent most of this decade at the mercy of a single question. How long will chipmakers keep spending? For years, nobody knew the answer. Fabrication plants planned in short cycles, and equipment suppliers assumed the boom would eventually slow down. That ...

Corrections & Amplifications
The Wall Street Journal33d agoneutral
Corrections & Amplifications

Marsh & McLennan is ranked No. 101 overall and Fiserv No. 386 overall in the Best Companies for the Future ranking of companies in the S&P 500 stock index as of Dec. 31, which Bendable Labs prepared for the WSJ Leadership Institute. The ranking published in the June 8 Journal Report incorrectly placed Marsh & McLennan at No. 275 because of errors in calculating its scores for AI readiness, innovation and financial fitness. Fiserv was incorrectly placed at No. 364 because of errors in calculating its scores for AI readiness and resilience.